Article
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
Ophthalmology - 1 Nov 2014
Chew Emily Y, Klein Michael L, Clemons Traci E, Agrón Elvira, Ratnapriya Rinki, Edwards Albert O, Fritsche Lars G, Swaroop Anand, Abecasis Gonçalo R
Abstract excerpt
OBJECTIVE: To determine whether genotypes at 2 major loci associated with late age-related macular degeneration (AMD), complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2), influence the relative benefits of Age-Related Eye Disease Study (AREDS) supplements. DESIGN: Unplanned retrospective evaluation of a prospective, randomized, placebo-controlled clinical trial of vitamins and minerals...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
